5612 Results

People

  1. Giralt
    Giralt
  2. Ladanyi
    Ladanyi
  3. Arcila
    Arcila
  4. Perales
    Perales
  5. Drilon
    Drilon
  6. Hyman
    Hyman
  7. Berger
    Berger
  8. Solit
    Solit
  9. Motzer
    Motzer
  10. Reis-Filho
    Reis-Filho

Groups

  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)
  7. Center for Hematologic Malignancies (914)
  8. Survivorship Research (910)
  9. Department of Pathology and Laboratory Medicine (784)
  10. Population Sciences Research Program (751)
  1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A prospective disease registry of patients with mantle cell lymphoma treated with novel agents: Treatment patterns, outcomes, and patient-reported health-related quality of life
    Meeting Abstract

    Ujjani, C.; Mato, A. R.; Cohen, J. B.; Svoboda, J.; Andorsky, D.; Goy, A.; Wang, M. L.; Kumar, A.; Torney, P. A.; Dawson, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • The genetic architecture of myeloproliferative neoplasms-blast phase (MPN-BP) stem cells
    Meeting Abstract

    Wang, X.; Rampal, R. K.; Hu, C. S.; Farnoud, N.; Famulare, C.; Patel, M. A.; McGovern, E.; Hoffman, R.
    Blood (2019)

    Fulltext@MSK | Save
  • Tolerability and efficacy of crenolanib and cytarabine/anthracycline chemotherapy in older patients (aged 61 to 75) with newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
    Meeting Abstract

    Wang, E. S.; Griffiths, E. A.; Walter, R. B.; Tallman, M. S.; Goldberg, A. D.; Messahel, B.; Stone, R. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Veneto-STOP study: Sequential assessment of minimal residual disease by next generation sequencing to optimize outcomes and minimize exposure in venetoclax-treated CLL patients
    Meeting Abstract

    Ujjani, C. S.; Roeker, L. E.; Shadman, M.; Whitaker, K. J.; Jacob, A. P.; Geyer, M. B.; Dorsey, C.; Zelenetz, A. D.; Mato, A. R.
    Blood (2019)

    Fulltext@MSK | Save
  • Epichaperome abundance predicts response to the epichaperome inhibitor, Puh-71, in acute myeloid leukemia
    Meeting Abstract

    Tavakkoli, M.; Kaner, J. D.; Sahil, S.; Taldone, T.; Merugu, S.; Chiosis, G.; Roboz, G. J.; Guzman, M. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Current selection patterns, toxicities and outcomes of pre-transplant salvage treatment regimens in patients with relapsed/refractory Hodgkin lymphoma: Results of a multicenter retrospective analysis
    Meeting Abstract

    Svoboda, J.; Ballard, H. J.; Bair, S. M.; Banerjee, R.; Andreadis, C.; Feldman, T. A.; McCarthy, E. L.; Khan, N.; Moskowitz, A. J.; Orellana-Noia, V. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A multicenter, open-label feasibility study of daratumumab with dose-adjusted EPOCH in newly diagnosed plasmablastic lymphoma: AIDS Malignancy Consortium 105
    Meeting Abstract

    Tan, C. R.; Barta, S. K.; Lensing, S. Y.; Noy, A.
    Blood (2019)

    Fulltext@MSK | Save
  • Development of HHV-6-specific immunity after cord blood transplantation in adults depends on reconstitution of thymopoiesis and regeneration of CD4(+) T cells
    Meeting Abstract

    Tijaro-Ovalle, N. M.; Li, S.; Defilipp, Z.; Politikos, I.; Joyce, R. M.; Armand, P.; Ho, V. T.; Koreth, J.; Nikiforow, S.; Alyea, E. P. 3rd; more...
    Blood (2019)

    Fulltext@MSK | Save
  • PRAME expression is correlated with treatment outcome and specific features of the tumor microenvironment in classical Hodgkin lymphoma
    Meeting Abstract

    Takata, K.; Chong, L. C.; Thakur, A.; Aoki, T.; Mottok, A.; Chavez, E.; Farinha, P.; Slack, G. W.; Hoodles, P.; Shah, S. P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients
    Meeting Abstract

    Thompson, J. C.; Ren, Y.; Romero, K. M.; Lew, M. V.; Bush, A. T.; Messina, J. A.; Jung, S. H.; Miller, J. M.; Zenko, Z.; Jenq, R. R.; more...
    Blood (2019)

    Fulltext@MSK | Save